| Literature DB >> 17766835 |
Bilal Ahmed1, Jaime A Tschen, Philip R Cohen, Mohamed H Zaki, Peter L Rady, Stephen K Tyring, Robert E Corringham, Razelle Kurzrock.
Abstract
Castleman's disease is uncommon, and cutaneous involvement is even rarer. We report a 42-year-old Asian woman with the multicentric plasma cell variant of Castleman's disease limited to her skin. The literature suggests that Castleman's disease is driven by interleukin-6 (IL-6). Based on these data, we hypothesized that suppression of IL-6 would have a salutary effect. Therefore, our patient was treated with CNTO328, a chimeric murine anti-human IL-6 antibody. She has shown a remarkable, ongoing response to this treatment, with almost complete clearing of her skin lesions after six doses.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17766835 DOI： 10.1158/1535-7163.MCT-07-0256
Source DB: PubMed Journal: Mol Cancer Ther ISSN： 1535-7163 Impact factor: 6.261